Pursuant to the provisions of Regulations 30 and 52 read with Schedule III of the Listing Regulations, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. on July 31, 2025, has, inter-alia, considered and approved:\r\n\r\n- the Statement of Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025, in accordance with the provisions of Regulations 33 and 52 of the Listing Regulations.\r\n\r\n- approved the appointment of Mr. Shwetank Singh as the Managing Director & CEO Designate. He will assume the role of Managing Director & CEO with effect from February 1, 2026.\r\n \r\nIt is also proposed that Dr. Sanjay Sethi will continue as a Non-Executive, Non-Independent Director, effective February 1, 2026.